Impact of treatment planning and delivery factors on gastrointestinal toxicity: an analysis of data from the RADAR prostate radiotherapy trial
Noorazrul Yahya, Martin A Ebert, Max Bulsara, Annette Haworth, Rachel Kearvell, Kerwyn Foo, Angel Kennedy, Sharon Richardson, Michele Krawiec, David J Joseph, Jim W Denham
Radiation Oncology | BIOMED CENTRAL LTD | Published : 2014
Awarded by Diagnostics and Technology Branch of the Australian Government Department of Health and Ageing
Awarded by National Health and Medical Research Council
We acknowledge funding from Cancer Australia and the Diagnostics and Technology Branch of the Australian Government Department of Health and Ageing (grant 501106), the National Health and Medical Research Council (grants 300705, 455521, 1006447), the Hunter Medical Research Institute, the Health Research Council (New Zealand), the University of Newcastle, the Calvary Mater Newcastle, Abbott Laboratories and Novartis Pharmaceuticals. We gratefully acknowledge the support of the Sir Charles Gairdner Hospital, the 'Elvis' study team, the contour audit team, participating RADAR centres, Chantelle Wilcox, Allison Steigler, the Trans-Tasman Radiation Oncology Group, Jean Ball, Cate Sproston, Sean Hall, Celia Gordon, Scott Chandler, Scott Williams, Mahesh Kumar, Sean Bydder, Rhonda Coleman, Ben Hooton, Elizabeth van der Wath.